CLNN
Clene Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.29
+6.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.44x
- P/S forward
- 4.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.87x
- Price / sales
- 234.94x
- Price / cash flow
- -2.91x
Enterprise value
- Enterprise value
- $59.0M
- EV / sales
- 299.27x
- EV / EBITDA
- -2.12x
- EV / EBIT
- -2.90x
- Market cap
- $46.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026